MIL-therapy / Method of treatment / 7.10. Gynecological disorders.
7.10. Gynecological disorders.
It has been shown that MIL-therapy increases the organism hormone saturation with estrogens and progesterone due to its stimulative effect on the ovaries. This is especially important in case of infertility. MIL-therapy also improves blood circulation in the pelvis and removes the irritation of vegetative nervous system caused by an inflammatory process thus, facilitating the functionability of the organs located in the pelvis.
Post-operative infiltrates, pericultitis at the late post-operative period, incomplete epithelization of pseudo erosion in the uterine neck after diathermoelectrocoagulation, salpyngitis, oophoritis, chronic salpyngoophoritis with a pain syndrome, adhesions in the pelvis, uterine infantility, sterility caused by the tube inpatency, algodysmenorrhea, vulva itching and kraurosis.
MIL-therapy is applied as an independent method or as a part of complex therapy in subacute and chronic inflammatory disorders in the female genitalia and in functional impairments.
The terminal is put (Fig. 27) on the abdominal wall in the area of ovaries projection (zones 7), uterine projection (zone 8), tube projection, on the sacrum (zones 6) or on the vulva (zone 9) depending on the nosology and the method applied. To perform the irradiation from the inside a special lightguide is attached to the apparatus. First, the lateral arches (zones 2) or the uterine neck ( total time is about 2-5 min) are irradiated, after that the terminal (without an attachment) is put on 1-2 painful zones in the area of Mikhaelis rhombus (zones 6) for 2 min on one zone.
If a woman is planning to have a baby or if she is treated for infertility the adnex projection on the front abdominal wall is not irradiated. The terminal is recommended to be put on the liver (zone 4), pancreas (zone 5), on the zones of Mikhaelis rhombus angles (zones 6). Impulse frequency is 80 Hz, LED radiation power is 40 mWt. 8-10 procedures for the course of treatment. MIL-therapy course may be repeated in 2-3 weeks.
Inflammatory process and pain syndrome decrease after 2-4 procedures. MIL-therapy effectiveness is controlled with biophotometry in the zones of uterine adnex projection (zones 7) on the abdominal wall before and right after the procedure (subcutaneous or intracavital). See Article 8 for details.
MIL-therapy is indicated on the second day after the uterine wall scraping to get antiinflammatory, analgesic and spasmolitic effects ( in combination with adequate antibacterial therapy). MIL-therapy session are performed daily (Fig. 27) intravaginally with a special attachment 2-3 times a day with an interval for 2,5-3 hours during 2-3 days (frequency 80 Hz, LED radiation power 50 mWt, exposure 2 min). Afterwards the irradiation is done transcutaneously: the terminal is put on the pubis ( zone 1, 8 - uterine projection) with a moderate compression of soft tissues, on the painful zones 6 (defined with palpation by a physician) on the sacrum (exposure 2 min on one zone); impulse frequency is 50 Hz, LED radiation power is 70 mWt. Procedures are performed daily once a day during 3-4 days.
The decrease of pain, body hyperthermia, bloody discharges from the uterine are seen 5-7 days earlier comparing to conventional therapy.
Fig. 28. Zones of MIL-irradiation for treating gynecologic disordersEndometrium hyperplasia
Hormone therapy of hyperplastic endometrium disorders is a basis of modern therapy directed towards the decrease of a proliferative potential of the organism. However, specific intolerance to hormonal preparations in combination with a wide range of contraindications limit their application in a great number of patients.
It has been found out that the level of different phosphoinozitides in the blood of patients with glandular endometrium hyperplasia and atypical endometrium hyperplasia is 1,3 and 1,6 times lower than in healthy women; and, in tissues affected by hyperplastic process it is 1,4 times higher on the average than in the intact endometrium. Normalizing phosphoinozitide content in the blood and endometrium tissue reduces a proliferative profile in the organism, thus preventing endometrium cells malignization as well.
MIL-irradiation is done (Fig. 28) on the iliac zones (zones 4), subpubic area (zone 5) , on the thymus projection (zone 2) and on the left subclavicular area (zone 1); ); impulse frequency is 50 Hz, LED radiation capacity power is 60 mWt, exposure time at one zone is 2 min. At first, 5 daily procedures are performed and then after a 7-day break the course is repeated.Two months later MIL-therapy course (10-12 procedures) is performed under the same scheme with additional irradiation of the zones on the plantar surfaces of feet (zones 3 and 6) for 0,5 min at one zone.
MIL-therapy in combination with phosphoinozitide preparations (phopholipid preparations containing phosphoinozitides in different combinations at positions D-3 and D-4 in the inozitol circlet) restores impaired phosphoinozitide exchange in patients with regulated and non-regulated proliferative disorders. Adding hormonal preparation Nonavlon to this therapeutical complex facilitates the restoration of a hormone profile in patients. Such complex therapy provides a stable therapeutic effect.
Fig. 29. Zones of MIL-irradiation for treating endometrium hyperplasia